BIAF · bioAffinity Technologies, Inc.
$0.40
+0.02 (+4.99%)
At close · Aug 14
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's current expected level of operating expenditures and the cash and cash equivalents on hand at June 30, 2026, management concludes that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Market Cap
$3.26M
Shares
8.10M
bioAffinity Technologies, Inc. Earnings Call Transcripts
Every quarterly earnings call for bioAffinity Technologies, Inc. (BIAF) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Key facts
CIK
1712762
CUSIP
09076W307
13F (30d)
21 filings
21 filers
Visit website
Investor relations